Needle with a novel attachment versus conventional screw-thread needles: A preference and usability test among adults with diabetes and impaired manual dexterity

Diabetes Technology and Therapeutics

Volumn 13, Issue 5, 2011, Pages 579-585

  Hansen, Birtha ^a   Lilleøre, Søren K ^b   Ter Borch, Gitte ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEUROPATHY; DRUG DELIVERY SYSTEM; FEMALE; HAND DISEASE; HAND TREMOR; HUMAN; IMPAIRED MANUAL DEXTERITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEEDLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBJECT MANIPULATION; OPEN STUDY; PARESIS; PARKINSON DISEASE; PATIENT PREFERENCE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF INJECTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; CROSS-OVER STUDIES; DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FEMALE; GREAT BRITAIN; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; ITALY; MALE; MATERIALS TESTING; MIDDLE AGED; NEEDLES; PATIENT PREFERENCE; SELF ADMINISTRATION; SELF-HELP DEVICES;

EID: 79955565226     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0214     Document Type: Article

References (49)

1. Bashoff EC, Beaser RS: Insulin therapy and the reluctant patient. Overcoming obstacles to success. Postgrad Med 1995;97:86-90, 93-96.
2. Fu AZ, Qiu Y, Radican L: Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin 2009;25:1413-1420.
3. Korytkowski M, Niskanen L, Asakura T: FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89-S100. (Pubitemid 43866930)
4. Mollema ED, Snoek FJ, Ader HJ, Heine RJ, van der Ploeg HM: Insulin-treated diabetes patients with fear of selfinjecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001;51:665-672. (Pubitemid 34007445)
5. Mollema ED, Snoek FJ, Heine RJ, van der Ploeg HM: Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 2001;18: 671-674. (Pubitemid 32823067)
6. Albano S: Assessment of quality of treatment in insulintreated patients with diabetes using a pre-filled insulin pen. The ORBITER Study Group. Acta Biomed 2004;75:34-39.
7. Bohannon NJ: Insulin delivery using pen devices. Simple-touse tools may help young and old alike. Postgrad Med 1999;106:57-58, 61-64, 68.
8. Chantelau E, Schiffers T, Schutze J, Hansen B: Effect of patient- selected intensive insulin therapy on quality of life. Patient Educ Couns 1997;30:167-173. (Pubitemid 27094790)
9. Kadiri A, Chraibi A, Marouan F, Ababou MR, el Guermai N, Wadjinny A, Kerfati A, Douiri M, Bensouda JD, Belkhadir J, Arvanitis Y: Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15-23. (Pubitemid 28394280)
10. Lombardo F, Salzano G, Messina MF, De Luca F: Compliance and administration methods in management of type 1 diabetes. Acta Biomed 2005;76(Suppl 3):66-69. (Pubitemid 351767168)
11. Summers KH, Szeinbach SL, Lenox SM: Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-1505. (Pubitemid 39572159)
12. Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA: Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995; 28:173-177.
13. Keith K, Nicholson D, Rogers D: Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74. (Pubitemid 38112268)
14. Lteif AN, Schwenk WF: Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-140. (Pubitemid 29028310)
15. Hornquist JO, Wikby A, Andersson PO, Dufva AM: Insulinpen treatment, quality of life and metabolic control: retrospective intra-group evaluations. Diabetes Res Clin Pract 1990;10:221-230.
16. Piscopo MA, Chiesa G, Bonfanti R, Viscardi M, Meschi F, Chiumello G: Quality of life and new devices in the management of type 1 diabetes in children and adolescents. Acta Biomed 2003;74(Suppl 1):21-25. (Pubitemid 36850818)
17. Tallroth G, Karlson B, Nilsson A, Agardh CD: The influence of different insulin regimens on quality of life and metabolic control in insulin-dependent diabetics. Diabetes Res Clin Pract 1989;6:37-43. (Pubitemid 19021833)
18. Hofman PL, Behrensdorf Derraik JG, Pinto TE, Tregurtha S, Faherty A, Peart JM, Drury PL, Robinson E, Tehranchi R, Donsmark M, Cutfield WS: Defining the ideal injection techniques when using 5-mm needles in children and adults. Diabetes Care 2010;33:1940-1944.
19. Iwanaga M, Kamoi K: Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles. Diabetes Technol Ther 2009;11:81-86.
20. McKay M, Compion G, Lytzen L: A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes. Diabetes Technol Ther 2009;11: 195-201.
21. Schwartz S, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W: A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6mm needle versus a 29 gauge × 12.7mm needle in obese patients with diabetes mellitus. Clin Ther 2004;26:1663-1678. (Pubitemid 39643027)
22. Gill HS, Prausnitz MR: Does needle size matter? J Diabetes Sci Technol 2007;1:725-729.
23. Solvig J: Needle length affects insulin deposition in normal and obese diabetes patients [abstract]. Diabetes 2001; 50(Suppl 2):A132.
24. Arendt-Nielsen L, Egekvist H, Bjerring P: Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res 2006;23:37-43. (Pubitemid 44114991)
25. Asakura T, Seino H: Handling and safety of two insulin injection pens (FlexPen- and OptiClik-) in insulin-naive type 2 diabetes patients [abstract]. Diabetes 2006;55(Suppl 1):A457.
26. Siegmund T, Blankenfeld H, Schumm-Draeger PM: Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study. Diabetes Technol Ther 2009;11:523-528.
27. Asakura T, Seino H: A comparison of the usability of two types of disposable pen (FlexPen versus Humalog Kit) containing rapid-acting insulin analogues [abstract]. Diabetes Metab 2003;29:S236.
28. Dreyer M: Comparison of metabolic control, safety, handling and patient acceptance of FlexPen with NovoLet in type 1 and type 2 diabetes patients. J Clin Res 2005;8:1-7. (Pubitemid 40733822)
29. Korytkowski M, Bell D, Jacobsen C, Suwannasari R: A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-2848. (Pubitemid 37510593)
30. Niskanen L, Jensen LE, Rastam J, Nygaard-Pedersen L, Erichsen K, Vora JP: Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther 2004;26:531-540. (Pubitemid 38586454)
31. Rubin RR, Peyrot M: Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-2497. (Pubitemid 39281409)
32. Asakura T, Seino H, Kageyama M, Yohkoh N: Evaluation of injection force of three insulin delivery pens. Expert Opin Pharmacother 2009;10:1389-1393.
33. Pfützner A, Reimer T, Frokjaer LPF, Jorgensen C: Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-2549.
34. Rissler J, Jorgensen C, Rye Hansen M, Hansen N-A: Evaluation of injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2217-2222.
35. Sommavilla B, Jorgensen C, Jensen KH: Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2223-2232.
36. Lytzen L, Ostfeldt L: Comparative assessment of NovoTwist ™, a novel insulin pen needle system [abstract]. Diabetes 2009;58(Suppl 1):A509.
37. Asakura T, Seino H, Nakano R, Muto T, Toraishi K, Sako Y, Kageyama M, Yohkoh N: A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technol Ther 2009;11:657-661.
38. Loseth S, Mellgren SI, Jorde R, Lindal S, Stalberg E: Polyneuropathy in type 1 and type 2 diabetes: comparison of nerve conduction studies, thermal perception thresholds and intraepidermal nerve fibre densities. Diabetes Metab Res Rev 2010;26:100-106.
39. Miralles-Garcia JM, de Pablos-Velasco P, Cabrerizo L, Perez M, Lopez-Gomez V: Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years' disease duration. Endocrinol Nutr 2010;57:414-420.
40. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-1579. (Pubitemid 36934465)
41. Ramchurn N, Mashamba C, Leitch E, Arutchelvam V, Narayanan K, Weaver J, Hamilton J, Heycock C, Saravanan V, Kelly C: Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med 2009;20:718-721.
42. Pfutzner J, Hellhammer J, Musholt PB, Pfutzner AH, Bohnke J, Hero T, Amann-Zalan I, Ganz M, Stephan P, Forst T, Pfutzner A: Evaluation of dexterity and cognitive capacity of patients with insulin treated diabetes mellitus. Diabetes 2009;58(Suppl 1):A478-A479.
43. Houtzagers CM, van der Velde EA: Multiple daily insulin injections: a multicentre study on acceptability and efficacy. Neth J Med 1988;33:16-25.
44. Houtzagers CM, Visser AP, Berntzen PA, van der Stap H, van Maarschalkerweerd WW, Heine RJ, van der Veen EA: Multiple daily insulin injections improve self-confidence. Diabet Med 1989;6:512-519. (Pubitemid 19184617)
45. Jefferson IG, Marteau TM, Smith MA, Baum JD: A multiple injection regimen using an insulin injection pen and prefilled cartridged soluble human insulin in adolescents with diabetes. Diabet Med 1985;2:493-495. (Pubitemid 16210034)
46. Murray DP, Keenan P, Gayer E, Salmon P, Tomkin GH, Drury MI, O'Sullivan DJ: A randomized trial of the efficacy and acceptability of a pen injector. Diabet Med 1988;5:750-754.
47. Rex J, Jensen KH, Lawton SA: A review of 20 years' experience with the NovoPen family of insulin injection devices. Clin Drug Investig 2006;26:367-401. (Pubitemid 43927053)
48. Saurbrey N, Arnold-Larsen S, Moller-Jensen B, Kuhl C: Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen. Diabet Med 1988;5:150-153. (Pubitemid 18063854)
49. Su CC, Chen HS, Lin HD: Glycemic control with different premixed insulin in Taiwanese people with type two diabetes mellitus. J Chin Med Assoc 2003;66:155-159.